Inventor profile of:

Peter Jarrett

City:

Burlington, Massachusetts

Country:

United States

Published Applications:

24

Last publication date:

2026-06-11

Top Assignees for applications by Peter Jarrett

The entities that hold a legal rights for patent applications filed by inventor Jarrett Peter:

Recent patent applications by Jarrett Peter

Peter Jarrett from Burlington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-11
US20260158187A1
Human necessities

OCULAR SEALANT FORMULATIONS AND SYSTEMS AND METHODS OF PREPARATION AND USE THEREOF

#2 | 2026-02-26
US20260053735A1
Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

#3 | 2025-07-10
US20250221848A1
Human necessities

IMPLANT INJECTOR DEVICE

#4 | 2025-03-20
US20250092013A1
Chemistry; metallurgy

PRODRUGS OF AXITINIB

#5 | 2025-02-20
US20250057759A1
Human necessities

SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE

#6 | 2024-11-28
US20240390183A1
Human necessities

INTRACANALICULAR DEPOT INSERTER DEVICE

#7 | 2024-08-29
US20240285518A1
Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

#8 | 2024-03-14
US20240082054A1
Human necessities

Intracanalicular depot inserter device

#9 | 2024-02-08
US20240042713A1
Performing operations; transporting

EXTRUDED OCULAR INSERTS OR IMPLANTS AND METHODS THEREOF

#10 | 2024-02-08
US20240041758A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

#11 | 2024-02-08
US20240041647A1
Human necessities

Implant injector device

#12 | 2023-12-07
US20230390189A1
Human necessities

OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT

#13 | 2023-10-26
US20230338281A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent

#14 | 2023-09-14
US20230285282A1
Human necessities

OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT

#15 | 2023-04-20
US20230118774A1
Human necessities

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

#16 | 2023-02-09
US20230040637A1
Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

#17 | 2022-11-03
US20220347094A1
Human necessities

Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor

#18 | 2022-06-30
US20220202706A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

#19 | 2022-03-24
US20220087932A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

#20 | 2022-03-24
US20220087931A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

#21 | 2022-03-17
US20220079876A1
Human necessities

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

#22 | 2021-10-07
US20210308043A1
Human necessities

Ocular implant containing a tyrosine kinase inhibitor

#23 | 2020-10-29
US20200337993A1
Human necessities

INTRACANALICULAR HYDROGEL INSERTS FOR THE DELIVERY OF ANESTHETICS

#24 | 2020-10-29
US20200337989A1
Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

InventorID:

2889042 ⎘